Down-regulation of TRPM2 expression or function contributes to decreased cancer cell proliferation and survival in many malignancies, such as breast, gastric, pancreatic, neuroblastoma, T-cell and acute myelogenous leukemia, and clear cell renal cell carcinoma [15,16,17,18,19]. Here, TRPM2 is linked to cancer.